New facility to support ground-breaking medical science research

Clinical trials specialist, Panthera Biopartners, has opened York’s first dedicated clinical research site.

The facility was officially opened by the Lord Mayor of York, Councillor Margaret Wells. It is in the Acomb Garth Community Centre, which is operated by local primary care services provider Nimbuscare, and features a suite of modern, private consultation rooms.

Panthera recruits patients and operates clinical trials at six dedicated clinical trial clinics across the UK on behalf of its global pharmaceutical and contract research organisation (CRO) clients.

The new clinic in York has been selected to run a major large scale flu vaccine study which will start in October as well as a variety of late-stage clinical studies including liver, respiratory, and cardiovascular disease.

It will go on to undertake studies across a variety of other therapeutic areas.

Panthera CEO, Stuart Young, said: “It is fantastic to have such strong local support from our partner Nimbuscare for the opening of our newest clinical research site in York.

“We are the first company to open a dedicated research site in York, so we are excited to be providing local healthcare professionals and patients with the opportunity to take part in clinical research.

“At Panthera we work with 10 out of the top 12 pharma companies and seven of the top CROs, so we look forward to bringing the very best clinical research and significant healthcare investment to the community of York”.

The Panthera York clinic will give patients and GPs the opportunity to participate in the latest ground-breaking clinical research.

Patient volunteers can also gain additional benefits from taking part in clinical research such as regular health assessments, access to new treatments, as well as helping to advance medical understanding for future generations.

Panthera launched in 2019 and runs a range of trials across multiple therapy areas including vaccines, cardiovascular, general medicine, neurology, respiratory, rheumatology and cancer.